Faeth Therapeutics, Inc. (FTH)
↓ Download CSVKey ratios (FY2025)
-113.4%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Income | -$22.29M | -$32.61M | -$37.06M | -$50.19M | -$37.48M | -$19.45M | — |
| Net Income | -$21.09M | -$30.16M | -$34.10M | -$48.59M | -$36.79M | -$20.10M | — |
| EPS (Diluted) | $-16.72 | $-24.01 | $-1.22 | $-1.58 | $-1.33 | — | — |
| Total Assets | $22.90M | $45.36M | $74.37M | $118.38M | $153.22M | $21.43M | — |
| Total Liabilities | $4.31M | $6.97M | $9.48M | $14.97M | $6.71M | $5.54M | — |
| Shareholders' Equity | $18.59M | $38.39M | $64.89M | $103.41M | $146.51M | -$56.44M | -$68.66M |
| Cash & Equivalents | $8.67M | $9.99M | $13.01M | $17.80M | $7.16M | $16.60M | — |
| Operating Cash Flow | -$20.45M | -$24.67M | -$32.02M | -$39.03M | -$30.26M | -$17.70M | — |
| Capital Expenditures | $16.0K | $146.0K | $180.0K | $321.0K | $2.03M | $1.21M | — |
| Shares Outstanding | 1.26M | 1.26M | 25.03M | 30.76M | 30.61M | 1.88M | — |